Total Funding
23
Total FundingSeries C raised
Growth Score
pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4627065
Lorantis develops products for the selective treatment of immunological and inflammatory diseases.
Acquired by 
Celldex Therapeutics Inc.
About the Company
Lorantis develops products for the selective treatment of immunological and inflammatory diseases. It develops therapeutics for immunological diseases, including allergy, asthma, autoimmune diseases, and transplant regulation.
The company is based in Cambridge, United Kingdom.
